Virus Filtration Market Size, Share and Global Trend By Product (Consumables, Instruments, Services), By Application (Biologicals, Medical devices, Water Purification, Air Filtration, Others), By End-User (Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations) and Regional Forecast, 2024-2032

In April 2015, a US-based subsidiary of Asahi Kasei Corporation, Asahi Kasei Bioprocess America started a customer training program for virus filtration, fluid management, and bioprocessing in their newly established Massachusetts Training Center. Virus filtration technology is extensively used in the purification of biopharmaceutical products. Unlike small molecules, biological drugs are formulated by using a mixture of animal, plants, and synthetic sources.

Therefore, there are potential chances of viral contamination. There are certain types of viruses commonly encountered while conducting research, such as Mouse Minute Virus, Cache Valley Virus, Reovirus, and others. Additionally, certain practices such as poor manufacturing processes, poor handling, and lack of safety measures are lead to viral contamination in biopharmaceutical products.

The global virus filtration market growth is being driven by increasing manufacturing of biologics and biopharmaceutical products. Moreover, the growing emphasis on implementation of safety measures is anticipated to drive the virus filtration market during the forecast period.

However, stringent government regulations and variation in regulatory laws enforced by government authorities are expected to hamper the growth of the global virus filtration market by 2026.

Key Players Covered

Some of the major companies covered in the global virus filtration market report are Asahi Kasei Medical Co. Ltd., General Electric Company, Danaher Corporation, Sartorius AG, Clean Cell Inc., Wuxi Biologics, Thermo Fischer Scientific Inc., Lonza Group Ltd, Charles River Laboratories International Inc., and others.

SEGMENTATION

As per current market trends, biological application segment is expected to hold a significant share of the market. Rapidly increasing FDA approvals for biological products coupled with the gradual shift of preference towards biologics is projected to lead biologic application segment during the forecast period.

Key Insights

• The regulatory scenario for key countries


• New product introduction by key players


• Recent developments in Virus Filtration devices


• Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

Based on the region, the global virus filtration market is segmented as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global virus filtration market owing to increased adoption of virus filters in medical as well as biopharmaceutical products manufacturing. In Europe, the virus filtration market is expected to witness huge growth owing to a growing number of research activities. The Asia Pacific and Latin America hold huge potential for the growth of the virus filtration market owing to increased adoption of virus filters for purification of air and water. Moreover, developing healthcare infrastructure in the Asia Pacific is expected to boost the production of biological products, which will eventually boost the adoption of virus filters during the forecast period.

Global Body Fat Measurement Market Industry Developments

• In March 2018, Pall Corporation launched its new division Pall Biotech. The newly launched division will focus on increasing efficiency and quality of biological products, viral vaccines, and virus filtration products. 
• In August 2016, Unilever announced an agreement to acquire Blueair, a considerable player in the air purification technologies and solutions.
• In June 2016, Sartorius AG, a Germany based virus filters manufacturing company launched Virosart Media, a new virus retention device. The newly launched device is cost-effective and it holds the capability to reduce the risk of virus contamination during the process of fermentation.